Skip to Main Content
Search this site:
Tell us your thoughts
How do you see the OPI index being integrated into an FDA submission?
Mark B Abelson
Dry Eye Summit 2010
Have topical agents or systemic drugs been used to treat dry eye?
What do we know about the enervation of the meibomian gland? What regulates MG lipid secretion?
Is MGD part of the differential diagnosis of dry eye or at the core of dry eye?
What is the effect of dry eye chamber patient selection on labeling language for drug indications?
How do Dry Eye chamber results correlate from mice to humans?
What is the value of quality of life questionnaires in dry eye studies?
Is mean change from baseline in a sign or symptom an acceptable endpoint for primary approval?
What endpoints might be appropriate for studying a neurotrophy dry eye product candidate?
Is OPI a validated endpoint? How it might be used towards an FDA approval?
Lessons Learned in the Dry Eye Application Process - Panel Introduction
© 2011, Dry Eye Summit.